CCL2 and glioblastoma: We treated GBM cells and PBMCs with IL-1β and found dramatically increased expression levels of the proinflammatory and tumor-promoting mediators COX2, IL-1β, CCL2, and IL-8 [33,34,35,36,37,38] in both GBM cells and PBMCs.